Latest news with #JBM
The Wire
2 days ago
- Politics
- The Wire
Jawahar Bal Manch Concludes National Training Camp 'AARAMB
~ 'India's future depends on building a better society,' says Netta D'Souza ~ New Delhi, July 14, 2025: The Indian National Congress, through its children's organization Jawahar Bal Manch (JBM), is committed to nurturing a new generation of socially conscious, constitutionally aware citizens who will contribute to building a progressive and inclusive nation. This was affirmed by Netta D'Souza, AICC National Organising Secretary, at the valedictory session of 'Aarambh', the national two-day JBM camp held at Indira Bhavan, New Delhi. D'Souza emphasized that Jawahar Bal Manch aims to instill Nehruvian ideals and constitutional values in young minds, thereby rebuilding the vision of a secular India through youth empowerment. 'Strengthening JBM's presence across all states is a key priority, as the Congress party believes that creating a value-based, inclusive society is fundamental to strong nation-building,' she said. The camp's chief guest, NSUI National President Varun Chaudhary, highlighted JBM's role in laying the ideological foundation for future leadership. 'Our goal is to produce educated, aware, and responsible individuals who uphold the Constitution. This is the Congress party's vision of constructive nation-building,' he said. Chaudhary also affirmed that students with experience in JBM and an understanding of Gandhian values will be given priority consideration in future NSUI organisational elections, recognising their early commitment to public service and leadership. The event was presided over by Dr. G.V. Hari, National Chairman, Jawahar Bal Manch. Under his leadership and the supervision of the national committee, two key initiatives were launched during the camp: the Indian Constitution Quiz for students under 16, and the Chacha Ji Gold Medal Drawing Competition. These national-level programs aim to enhance civic understanding and creative expression among children and will be conducted across the country. JBM National Office Bearers also announced the upcoming National Representative Convention to be held in Jaipur on September 11,12 and 13, 2025, which will host over 200 student delegates and senior leaders including Rahul Gandhi. The 'Aarambh' camp served as a preparatory event for this major gathering. As part of its digital outreach, JBM will also launch its official platforms - Kids TV and a YouTube Channel on July 14, 2025. The launch will be officiated by AICC General Secretary K.C. Venugopal. The closing session was addressed by JBM National Chief Coordinator Adv. Yogesh Sharma, and national committee members Gunjan Sharma, Vaishakha Rinich, Rahul T, Tayyab Shahid, and Naresh Kumar. (Disclaimer: The above press release comes to you under an arrangement with NRDPL and PTI takes no editorial responsibility for the same.). This is an auto-published feed from PTI with no editorial input from The Wire.
Yahoo
22-06-2025
- Business
- Yahoo
Top 3 Asian Penny Stocks With Market Caps Over US$100M To Watch
As global markets navigate a landscape of mixed economic signals, Asia continues to be a focal point for investors seeking opportunities in emerging sectors. Penny stocks, though an older term, still capture the essence of investing in smaller or newer companies that may offer significant growth potential. By focusing on those with strong financials and promising outlooks, investors can uncover valuable opportunities within this often-overlooked segment of the market. Name Share Price Market Cap Financial Health Rating JBM (Healthcare) (SEHK:2161) HK$2.87 HK$2.34B ★★★★★★ Lever Style (SEHK:1346) HK$1.24 HK$782.38M ★★★★★★ KPa-BM Holdings (SEHK:2663) HK$0.32 HK$178.22M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.10 HK$1.75B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.14 HK$1.9B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.25 SGD8.86B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.175 SGD34.86M ★★★★★★ BRC Asia (SGX:BEC) SGD3.12 SGD855.97M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.68 HK$53.61B ★★★★★★ Click here to see the full list of 1,168 stocks from our Asian Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang Shibao Company Limited, along with its subsidiaries, focuses on the research, design, development, production, and sale of automotive steering systems and accessories in China with a market cap of HK$8.58 billion. Operations: Zhejiang Shibao Company Limited has not reported any specific revenue segments. Market Cap: HK$8.58B Zhejiang Shibao Company Limited has shown robust financial health and growth, with earnings increasing by 95.8% over the past year, surpassing industry averages. The company maintains a strong balance sheet with short-term assets of CN¥2.2 billion exceeding both short-term and long-term liabilities significantly, while operating cash flow comfortably covers its debt obligations. Recent earnings reports reflect substantial revenue growth from CNY 1,819.44 million to CNY 2,693.47 million year-on-year, alongside improved net profit margins from 4.6% to 6%. Additionally, the company announced a dividend increase for shareholders in May 2025. Jump into the full analysis health report here for a deeper understanding of Zhejiang Shibao. Understand Zhejiang Shibao's track record by examining our performance history report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: China Wantian Holdings Limited operates in the green food supply, catering chain, and environmental protection and technology sectors across the People's Republic of China, Seychelles, Samoa, and the British Virgin Islands with a market cap of approximately HK$2.69 billion. Operations: The company's revenue is primarily derived from food supply (HK$750.39 million), followed by catering services (HK$37.42 million) and environmental protection and technology services (HK$0.82 million). Market Cap: HK$2.69B China Wantian Holdings Limited operates with a market cap of approximately HK$2.69 billion, primarily generating revenue from its green food supply sector (HK$750.39 million). Despite being unprofitable with a net loss of HK$41.99 million for the year ended December 2024, the company has managed to reduce its debt to equity ratio significantly over five years, reflecting improved financial management. Short-term assets comfortably cover both short and long-term liabilities, providing some financial stability. Recent executive changes may impact strategic direction as Ms. Shum Ching Yee Jennifer brings extensive experience in corporate finance and accounting to her new roles within the company. Get an in-depth perspective on China Wantian Holdings' performance by reading our balance sheet health report here. Explore historical data to track China Wantian Holdings' performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: JW (Cayman) Therapeutics Co. Ltd is a clinical stage cell therapy company focused on the research, development, manufacture, and marketing of cellular immunotherapy products in China, with a market cap of approximately HK$1.05 billion. Operations: The company's revenue is primarily generated from its Pharmaceuticals segment, amounting to CN¥158.22 million. Market Cap: HK$1.05B JW (Cayman) Therapeutics, with a market cap of HK$1.05 billion, focuses on cellular immunotherapy in China and has reported CN¥158.22 million in revenue from its pharmaceutical segment. Despite being currently unprofitable, the company has improved its financial position by reducing losses over the past five years and maintaining more cash than debt. Recent developments include a significant product-related announcement where Carteyva® received acceptance for a supplemental Biological License Application as second-line treatment for relapsed or refractory large B-cell lymphoma, supported by promising clinical trial results showing high response rates and manageable side effects. Dive into the specifics of JW (Cayman) Therapeutics here with our thorough balance sheet health report. Examine JW (Cayman) Therapeutics' earnings growth report to understand how analysts expect it to perform. Investigate our full lineup of 1,168 Asian Penny Stocks right here. Want To Explore Some Alternatives? This technology could replace computers: discover the 26 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1057 SEHK:1854 and SEHK:2126. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
18-06-2025
- Business
- Yahoo
Asian Market Gems: 3 Penny Stocks Under US$1B Market Cap
As geopolitical tensions in the Middle East escalate and trade discussions between major economies continue, Asian markets are navigating a complex landscape. Within this context, penny stocks—often smaller or newer companies—remain a focal point for investors seeking growth opportunities. Despite their reputation as speculative investments, those with strong financials can offer compelling value and potential upside. Name Share Price Market Cap Financial Health Rating JBM (Healthcare) (SEHK:2161) HK$2.92 HK$2.38B ★★★★★★ Lever Style (SEHK:1346) HK$1.22 HK$769.76M ★★★★★★ Advice IT Infinite (SET:ADVICE) THB4.84 THB3B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.16 HK$1.8B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.445 SGD180.35M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.19 HK$1.99B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.30 SGD9.05B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.179 SGD35.66M ★★★★★★ BRC Asia (SGX:BEC) SGD3.14 SGD861.46M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.64 HK$53.16B ★★★★★★ Click here to see the full list of 1,154 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★★★ Overview: K. Wah International Holdings Limited is an investment holding company involved in property development and investment in Hong Kong and Mainland China, with a market cap of HK$5.93 billion. Operations: The company's revenue is primarily derived from property development in Mainland China (HK$5.91 billion) and Hong Kong (HK$540.49 million), along with property investment activities generating HK$642.97 million. Market Cap: HK$5.93B K. Wah International Holdings, with a market cap of HK$5.93 billion, derives significant revenue from property development and investment in Hong Kong and Mainland China, totaling HK$7.19 billion in 2024. Despite stable weekly volatility and satisfactory debt levels, the company faces challenges including declining earnings growth over the past year and reduced profit margins compared to previous years. Recent executive changes include appointing Mr. Francis Lui as Chairman of the Board while co-managing directors were named to guide operations forward. The board recommended a lower final cash dividend for 2024 compared to the previous year's distribution. Click here and access our complete financial health analysis report to understand the dynamics of K. Wah International Holdings. Review our growth performance report to gain insights into K. Wah International Holdings' future. Simply Wall St Financial Health Rating: ★★★★★★ Overview: UMS Integration Limited, with a market cap of SGD873.96 million, is an investment holding company that manufactures and markets precision machining components while also offering electromechanical assembly and final testing services. Operations: The company's revenue is primarily derived from its Semiconductor segment, which accounts for SGD207.51 million, followed by the Aerospace segment with SGD27.43 million. Market Cap: SGD873.96M UMS Integration Limited, with a market cap of SGD873.96 million, has shown financial resilience in the penny stock arena through its strong asset management, as short-term assets significantly exceed both long and short-term liabilities. The company benefits from a low debt-to-equity ratio and high-quality earnings despite recent negative earnings growth of -22.5%. Recent board changes aim to strengthen governance with new independent directors appointed to key committees. However, profit margins have declined from 19.2% to 16.5% over the past year, and dividends are not well covered by free cash flows, indicating potential challenges ahead for investors. Unlock comprehensive insights into our analysis of UMS Integration stock in this financial health report. Examine UMS Integration's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Beijing Watertek Information Technology Co., Ltd. operates in the information technology sector, focusing on providing security solutions and services, with a market cap of CN¥6.86 billion. Operations: The company generates its revenue of CN¥2.73 billion from the Software and Information Technology Services Industry segment. Market Cap: CN¥6.86B Beijing Watertek Information Technology, with a market cap of CN¥6.86 billion, operates in the IT security sector and faces challenges typical of penny stocks, such as volatility and unprofitability. Despite this, its short-term assets exceed both short and long-term liabilities, suggesting solid asset management. The company has reduced its debt-to-equity ratio over five years and maintains a cash runway exceeding three years if current cash flow trends persist. Recent earnings reports indicate stable revenue but increased net losses year-over-year. Management's experience averages 4.5 years, providing some stability amidst financial hurdles. Click here to discover the nuances of Beijing Watertek Information Technology with our detailed analytical financial health report. Evaluate Beijing Watertek Information Technology's historical performance by accessing our past performance report. Unlock more gems! Our Asian Penny Stocks screener has unearthed 1,151 more companies for you to here to unveil our expertly curated list of 1,154 Asian Penny Stocks. Looking For Alternative Opportunities? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:173 SGX:558 and SZSE:300324. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
18-06-2025
- Business
- Yahoo
Asian Market Gems: 3 Penny Stocks Under US$1B Market Cap
As geopolitical tensions in the Middle East escalate and trade discussions between major economies continue, Asian markets are navigating a complex landscape. Within this context, penny stocks—often smaller or newer companies—remain a focal point for investors seeking growth opportunities. Despite their reputation as speculative investments, those with strong financials can offer compelling value and potential upside. Name Share Price Market Cap Financial Health Rating JBM (Healthcare) (SEHK:2161) HK$2.92 HK$2.38B ★★★★★★ Lever Style (SEHK:1346) HK$1.22 HK$769.76M ★★★★★★ Advice IT Infinite (SET:ADVICE) THB4.84 THB3B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.16 HK$1.8B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.445 SGD180.35M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.19 HK$1.99B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.30 SGD9.05B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.179 SGD35.66M ★★★★★★ BRC Asia (SGX:BEC) SGD3.14 SGD861.46M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.64 HK$53.16B ★★★★★★ Click here to see the full list of 1,154 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★★★ Overview: K. Wah International Holdings Limited is an investment holding company involved in property development and investment in Hong Kong and Mainland China, with a market cap of HK$5.93 billion. Operations: The company's revenue is primarily derived from property development in Mainland China (HK$5.91 billion) and Hong Kong (HK$540.49 million), along with property investment activities generating HK$642.97 million. Market Cap: HK$5.93B K. Wah International Holdings, with a market cap of HK$5.93 billion, derives significant revenue from property development and investment in Hong Kong and Mainland China, totaling HK$7.19 billion in 2024. Despite stable weekly volatility and satisfactory debt levels, the company faces challenges including declining earnings growth over the past year and reduced profit margins compared to previous years. Recent executive changes include appointing Mr. Francis Lui as Chairman of the Board while co-managing directors were named to guide operations forward. The board recommended a lower final cash dividend for 2024 compared to the previous year's distribution. Click here and access our complete financial health analysis report to understand the dynamics of K. Wah International Holdings. Review our growth performance report to gain insights into K. Wah International Holdings' future. Simply Wall St Financial Health Rating: ★★★★★★ Overview: UMS Integration Limited, with a market cap of SGD873.96 million, is an investment holding company that manufactures and markets precision machining components while also offering electromechanical assembly and final testing services. Operations: The company's revenue is primarily derived from its Semiconductor segment, which accounts for SGD207.51 million, followed by the Aerospace segment with SGD27.43 million. Market Cap: SGD873.96M UMS Integration Limited, with a market cap of SGD873.96 million, has shown financial resilience in the penny stock arena through its strong asset management, as short-term assets significantly exceed both long and short-term liabilities. The company benefits from a low debt-to-equity ratio and high-quality earnings despite recent negative earnings growth of -22.5%. Recent board changes aim to strengthen governance with new independent directors appointed to key committees. However, profit margins have declined from 19.2% to 16.5% over the past year, and dividends are not well covered by free cash flows, indicating potential challenges ahead for investors. Unlock comprehensive insights into our analysis of UMS Integration stock in this financial health report. Examine UMS Integration's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Beijing Watertek Information Technology Co., Ltd. operates in the information technology sector, focusing on providing security solutions and services, with a market cap of CN¥6.86 billion. Operations: The company generates its revenue of CN¥2.73 billion from the Software and Information Technology Services Industry segment. Market Cap: CN¥6.86B Beijing Watertek Information Technology, with a market cap of CN¥6.86 billion, operates in the IT security sector and faces challenges typical of penny stocks, such as volatility and unprofitability. Despite this, its short-term assets exceed both short and long-term liabilities, suggesting solid asset management. The company has reduced its debt-to-equity ratio over five years and maintains a cash runway exceeding three years if current cash flow trends persist. Recent earnings reports indicate stable revenue but increased net losses year-over-year. Management's experience averages 4.5 years, providing some stability amidst financial hurdles. Click here to discover the nuances of Beijing Watertek Information Technology with our detailed analytical financial health report. Evaluate Beijing Watertek Information Technology's historical performance by accessing our past performance report. Unlock more gems! Our Asian Penny Stocks screener has unearthed 1,151 more companies for you to here to unveil our expertly curated list of 1,154 Asian Penny Stocks. Looking For Alternative Opportunities? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:173 SGX:558 and SZSE:300324. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-06-2025
- Business
- Yahoo
Discover 3 Asian Penny Stocks With Over US$90M Market Cap
Amid escalating geopolitical tensions and trade-related concerns, Asian markets have experienced mixed performance, reflecting broader global economic uncertainties. In such a climate, investors often turn their attention to smaller or newer companies that may offer unique opportunities for growth. While the term "penny stocks" might seem outdated, it still signifies companies with potential value hidden beneath their modest market prices. By focusing on those with solid financials and clear growth potential, investors can uncover promising opportunities in this segment of the market. Name Share Price Market Cap Financial Health Rating YKGI (Catalist:YK9) SGD0.104 SGD44.2M ★★★★★★ JBM (Healthcare) (SEHK:2161) HK$2.74 HK$2.23B ★★★★★★ Lever Style (SEHK:1346) HK$1.19 HK$750.83M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.455 SGD184.41M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.18 HK$1.97B ★★★★★★ Halcyon Technology (SET:HTECH) THB2.60 THB780M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.25 SGD8.86B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.181 SGD36.06M ★★★★★★ BRC Asia (SGX:BEC) SGD3.13 SGD858.72M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.61 HK$52.81B ★★★★★★ Click here to see the full list of 1,158 stocks from our Asian Penny Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Logory Logistics Technology Co., Ltd. offers road freight transportation services and solutions to various stakeholders in the logistics industry in China, with a market cap of HK$1.73 billion. Operations: The company's revenue of CN¥7.54 billion is generated from its digital freight businesses and related services. Market Cap: HK$1.73B Logory Logistics Technology, with a market cap of HK$1.73 billion, has shown significant financial improvement by becoming profitable this year. Its revenue stands at CN¥7.54 billion, driven by its digital freight services in China. The company maintains a solid financial position with short-term assets exceeding both short and long-term liabilities and more cash than total debt. Recent changes include the appointment of Long Ke as an executive director and amendments to the Articles of Association to allow for potential share issuance adjustments, reflecting strategic governance updates aimed at enhancing operational flexibility and growth prospects in the logistics sector. Jump into the full analysis health report here for a deeper understanding of Logory Logistics Technology. Gain insights into Logory Logistics Technology's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Uni-Bio Science Group Limited is an investment holding company that focuses on the research, development, manufacturing, and sale of biological and chemical pharmaceutical products for treating human diseases in China, with a market cap of HK$746.40 million. Operations: The company generates revenue from its Chemical Pharmaceutical Products segment, contributing HK$249.62 million, and its Biological Pharmaceutical Products segment, which brings in HK$303.36 million. Market Cap: HK$746.4M Uni-Bio Science Group, with a market cap of HK$746.40 million, has demonstrated financial stability and growth potential in the biotech sector. The company reported revenues of HK$552.98 million for 2024, with net income rising to HK$82.77 million from the previous year. Its short-term assets significantly exceed liabilities, ensuring liquidity strength while maintaining a high Return on Equity at 25.4%. Recent approval for Diquafosol Sodium Eye Drops by China's National Medical Products Administration enhances its ophthalmology portfolio, promising further market penetration amidst growing demand for dry eye treatments in China's expanding healthcare market. Navigate through the intricacies of Uni-Bio Science Group with our comprehensive balance sheet health report here. Assess Uni-Bio Science Group's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Beijing Kingee Culture Development Co., Ltd. operates in the cultural and creative industries, focusing on design and production services, with a market cap of CN¥9.31 billion. Operations: There are no reported revenue segments for Beijing Kingee Culture Development Co., Ltd. Market Cap: CN¥9.31B Beijing Kingee Culture Development, with a market cap of CN¥9.31 billion, operates in the cultural and creative industries. Despite being unprofitable, it reported Q1 2025 sales of CN¥144.17 million, an increase from the previous year. The company has no debt and strong liquidity with short-term assets of CN¥2.1 billion surpassing its liabilities significantly, indicating financial resilience despite current losses. Its board is experienced with an average tenure of 3.7 years, although management experience data is insufficient. Shareholders have not faced dilution recently, which may appeal to investors seeking stability in equity value amidst volatile penny stock markets. Click here to discover the nuances of Beijing Kingee Culture Development with our detailed analytical financial health report. Understand Beijing Kingee Culture Development's track record by examining our performance history report. Dive into all 1,158 of the Asian Penny Stocks we have identified here. Ready To Venture Into Other Investment Styles? This technology could replace computers: discover the 24 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2482 SEHK:690 and SZSE:002721. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
